申请人:——
公开号:US20040023995A1
公开(公告)日:2004-02-05
Novel pyridopyrimidine-based compounds are found to be useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling.
小说嘧啶并[3,4-d]吡啶基化合物被发现可用于治疗或预防因细胞因子内部信号传导受到影响而引起的疾病或障碍的症状或表现。